$3.25 Billion is the total value of Redmile Group, LLC's 83 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $174,444,000 | +15.0% | 4,218,717 | +2.2% | 5.37% | +4.2% |
| FATE | Buy | FATE THERAPEUTICS INC | $168,759,000 | +123.6% | 10,359,666 | +55.6% | 5.19% | +102.5% |
| RGNX | Buy | REGENXBIO INC | $125,033,000 | +11.6% | 1,656,065 | +6.1% | 3.85% | +1.1% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $113,665,000 | +32.4% | 2,273,307 | +1.3% | 3.50% | +19.9% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $88,814,000 | +4.3% | 2,243,356 | +0.7% | 2.73% | -5.6% |
| CI | New | CIGNA CORPORATION | $77,094,000 | – | 370,200 | +100.0% | 2.37% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $73,907,000 | +32.5% | 974,506 | +44.7% | 2.27% | +20.0% |
| ALLK | New | ALLAKOS INC | $65,681,000 | – | 1,459,892 | +100.0% | 2.02% | – |
| ANTM | Buy | ANTHEM INC | $64,128,000 | +84.5% | 234,000 | +60.3% | 1.97% | +67.1% |
| WMGI | New | WRIGHT MED GROUP N V | $63,081,000 | – | 2,173,700 | +100.0% | 1.94% | – |
| ANAB | Buy | ANAPTYSBIO INC | $62,880,000 | +70.5% | 630,250 | +21.4% | 1.94% | +54.4% |
| QURE | Buy | UNIQURE NV | $59,676,000 | -2.8% | 1,639,900 | +1.0% | 1.84% | -12.0% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $52,229,000 | -34.7% | 1,778,300 | +1.1% | 1.61% | -40.8% |
| TNDM | New | TANDEM DIABETES CARE INC | $45,825,000 | – | 1,069,670 | +100.0% | 1.41% | – |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $45,658,000 | +67.2% | 1,773,107 | +1.3% | 1.40% | +51.4% |
| NITE | Buy | NIGHTSTAR THERAPEUTICS PLCadr | $42,512,000 | +48.8% | 2,080,846 | +16.5% | 1.31% | +34.8% |
| EHTH | Buy | EHEALTH INC | $41,616,000 | +36.7% | 1,472,595 | +6.9% | 1.28% | +23.8% |
| HSKA | Buy | HESKA CORP | $40,982,000 | +11.3% | 361,676 | +1.9% | 1.26% | +0.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $38,794,000 | +10.6% | 145,820 | +2.0% | 1.19% | +0.2% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $36,281,000 | +25.9% | 2,235,407 | +0.0% | 1.12% | +14.0% |
| REPL | New | REPLIMUNE GROUP INC | $35,307,000 | – | 2,192,957 | +100.0% | 1.09% | – |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $33,169,000 | -16.4% | 2,993,565 | +1.2% | 1.02% | -24.3% |
| PEN | Buy | PENUMBRA INC | $32,504,000 | +226.0% | 217,129 | +200.9% | 1.00% | +195.0% |
| GRTS | New | GRITSTONE ONCOLOGY INC | $31,935,000 | – | 2,242,636 | +100.0% | 0.98% | – |
| NUVA | New | NUVASIVE INC | $31,210,000 | – | 439,700 | +100.0% | 0.96% | – |
| CVS | New | CVS HEALTH CORP | $31,039,000 | – | 394,300 | +100.0% | 0.96% | – |
| CTLT | Buy | CATALENT INC | $30,466,000 | +9.9% | 668,850 | +1.1% | 0.94% | -0.5% |
| GLYC | Buy | GLYCOMIMETICS INC | $29,493,000 | -9.9% | 2,048,147 | +0.9% | 0.91% | -18.4% |
| TDOC | Buy | TELADOC HEALTH INC | $28,901,000 | +115.5% | 334,700 | +44.9% | 0.89% | +95.0% |
| PRQR | New | PROQR THRAPEUTICS N V | $28,075,000 | – | 1,450,925 | +100.0% | 0.86% | – |
| EPZM | Buy | EPIZYME INC | $23,831,000 | -13.0% | 2,248,189 | +11.2% | 0.73% | -21.2% |
| ZTS | Buy | ZOETIS INCcl a | $23,192,000 | +9.3% | 253,300 | +1.7% | 0.71% | -1.0% |
| LHCG | New | LHC GROUP INC | $22,398,000 | – | 217,480 | +100.0% | 0.69% | – |
| PRAH | New | PRA HEALTH SCIENCES INC | $22,038,000 | – | 200,000 | +100.0% | 0.68% | – |
| A | New | AGILENT TECHNOLOGIES INC | $21,613,000 | – | 306,400 | +100.0% | 0.66% | – |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $19,725,000 | +18.4% | 1,656,138 | +1.5% | 0.61% | +7.2% |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $18,317,000 | – | 525,000 | +100.0% | 0.56% | – |
| CMRX | Buy | CHIMERIX INC | $13,969,000 | -18.2% | 3,591,050 | +0.0% | 0.43% | -25.9% |
| SGRY | Buy | SURGERY PARTNERS INC | $10,468,000 | +13.1% | 634,400 | +2.1% | 0.32% | +2.5% |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $8,660,000 | +122.9% | 867,700 | +354.3% | 0.27% | +101.5% |
| IIN | New | INTRICON CORP | $7,025,000 | – | 125,000 | +100.0% | 0.22% | – |
| OVID | Buy | OVID THERAPEUTICS INC | $4,140,000 | +335.3% | 730,150 | +498.7% | 0.13% | +296.9% |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $3,615,000 | – | 150,000 | +100.0% | 0.11% | – |
| ARVN | New | ARVINAS INC | $2,299,000 | – | 136,300 | +100.0% | 0.07% | – |
| RMED | New | RA MED SYS INC | $1,547,000 | – | 85,000 | +100.0% | 0.05% | – |
| RGEN | New | REPLIGEN CORP | $1,109,000 | – | 20,000 | +100.0% | 0.03% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $523,000 | – | 30,000 | +100.0% | 0.02% | – |
| HRTX | New | HERON THERAPEUTICS INC | $343,000 | – | 10,850 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-10 |
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.